Search Results for: AKEL

October 5, 2019October 5, 2019

NIH Grant Awarded to Akelos Collaborator, Funds Work to Develop Non-Opioid Drugs for Neuropathic Pain

Opioids News

Publication date: Oct 05, 2019 A grant from the National Institutes of Health awarded to a Weill Cornell Medicine investigator will bolster Akelos Inc. -supported research to develop a non-opioid ... Read more

November 27, 2019November 27, 2019

How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape?

Multiple Sclerosis Media

Publication date: Nov 26, 2019 Management of multiple sclerosis (MS) occurs in a rapidly changing environment in which decisions must be made using the latest available data and insights. This ... Read more

November 2, 2019November 2, 2019

Chronic opioid use and long-term mortality: a global problem.

Opioids Literature

Publication date: Oct 28, 2019 Poeran, J. and Memtsoudis, S.G. Chronic opioid use and long-term mortality: a global problem. 04182. 2019 Br J Anaesth. Concepts Keywords Mortality Heroin Opioid Euphoriants ... Read more

October 31, 2019October 31, 2019

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

Opioids News

Publication date: Oct 31, 2019 SMITHS FALLS, ON, Oct. 30, 2019 (Canada NewsWire via COMTEX) — Spectrum Therapeutics, the medical division of Canopy Growth Corporation (“Canopy Growth”) (WEED) CGC, -1. ... Read more

October 26, 2019October 26, 2019

Lipidomics: Current state of the art in a fast moving field.

Precision Medicine Literature

Publication date: Oct 23, 2019 Lipids are essential for all facets of life. They play three major roles: energy metabolism, structural, and signaling. They are dynamic molecules strongly influenced by ... Read more

October 11, 2019October 11, 2019

Emmes Awarded New NIH Contracts that Address the Nation’s Opioid Addiction Crisis

Opioids News

Publication date: Oct 11, 2019 The Company is Hiring Additional Staff to Support its Awards Totaling Over $9 Million ROCKVILLE, Md. , Oct. 10, 2019 /PRNewswire/ — Emmes today announced ... Read more

September 14, 2019September 14, 2019

Prognosis and Management of Thick and Ultrathick Melanoma.

Melanoma Literature

Publication date: Sep 11, 2019 Thick melanomas, defined as ≥4 mm in thickness, represent ~5% of new melanoma diagnoses and have been associated with poor overall survival (OS). Ultrathick melanomas, those ... Read more

August 23, 2019August 23, 2019

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

Melanoma Literature

Publication date: Aug 20, 2019 Reprogrammed metabolism and cell cycle dysregulation are two cancer hallmarks. p16 is a cell cycle inhibitor and tumor suppressor that is upregulated during oncogene-induced senescence ... Read more

August 3, 2019August 3, 2019

Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining.

Precision Medicine Literature

Publication date: Jul 30, 2019 A major challenge in cancer treatment is predicting the clinical response to anti-cancer drugs on a personalized basis. The success of such a task largely ... Read more

July 11, 2019July 11, 2019

Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response.

Melanoma Literature

Publication date: Jul 08, 2019 A major hurdle in the advancement of cell-based cancer immunotherapies is the inability to track in vivo therapeutic cell migration. With respect to dendritic cell ... Read more